Liver cytoprotection by prostaglandins
- 1 January 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 58 (1) , 67-92
- https://doi.org/10.1016/0163-7258(93)90067-n
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- LEUKOCYTE ADHESION AND CELL DEATH FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION IN THE RATTransplantation, 1991
- Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and PrednisoneNew England Journal of Medicine, 1990
- Study of 16,16-Dimethyl Prostaglandin E2for Prevention of Stress Ulcer after Hepatectomy of Experimental Cirrhotic Liver and Its Influence on Hepatic RegenerationScandinavian Journal of Gastroenterology, 1990
- Leukotrienes as Mediators in Diseases of the LiverSeminars in Liver Disease, 1988
- Release of peptide leukotrienes from rat kupffer cellsBiochemical and Biophysical Research Communications, 1988
- Leukotrienes increase glucose and lactate output and decrease flow in perfused rat liverBiochemical and Biophysical Research Communications, 1988
- Cultured Ito cells of rat liver express the alpha2-macroglobulin geneEuropean Journal of Biochemistry, 1987
- 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.Journal of Clinical Investigation, 1987
- Cytoprotective effect of prostaglandins on isolated rat liver cellsLiver International, 1985
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985